Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)

SHA:605266 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	711.63	776.05	857.93	932.6	983.1	1,622
Trading Asset Securities	30	50	50	3	-	-
Cash & Short-Term Investments	741.63	826.05	907.93	935.6	983.1	1,622
Cash Growth	-4.94%	-9.02%	-2.96%	-4.83%	-39.38%	265.82%
Accounts Receivable	442.67	425.75	440.48	591.65	227.87	166.7
Other Receivables	62.05	60.68	56.94	53.54	56.96	32.73
Receivables	504.73	486.44	497.42	645.19	284.83	199.43
Inventory	2,825	3,128	2,374	2,166	1,121	731.43
Prepaid Expenses	-	14.04	12.87	-	-	-
Other Current Assets	225.88	228.09	145.79	192.89	107.8	240.93
Total Current Assets	4,298	4,683	3,938	3,939	2,497	2,793
Property, Plant & Equipment	2,518	2,597	2,687	2,644	1,901	376.87
Long-Term Investments	28.95	30.54	47.42	18.34	9.8	-
Goodwill	2,456	2,456	2,403	2,243	415.3	57.58
Other Intangible Assets	82.22	85.36	92.2	90.46	44.75	33.52
Long-Term Deferred Tax Assets	273.47	280.17	285.43	287.22	14.64	5.96
Long-Term Deferred Charges	450.51	485.3	485.93	415.89	331.86	201.18
Other Long-Term Assets	7.31	6.05	10.61	6.18	-	-
Total Assets	10,115	10,623	9,949	9,644	5,214	3,469
Accounts Payable	2,248	2,783	2,639	2,756	1,695	1,426
Accrued Expenses	140.13	184.59	216.07	281.91	105.3	111.36
Short-Term Debt	1,902	1,604	749.61	201.48	30	74.08
Current Portion of Long-Term Debt	647.03	249.74	572.5	155.19	5.41	-
Current Portion of Leases	-	389.42	423.84	422.6	378.41	-
Current Income Taxes Payable	43.24	19.77	44.93	66.87	42.42	23.9
Current Unearned Revenue	26.27	25.23	28.49	37.43	18.07	12.44
Other Current Liabilities	145.69	212.14	185.57	304.14	146.67	70.85
Total Current Liabilities	5,152	5,467	4,860	4,225	2,421	1,719
Long-Term Debt	1,101	1,190	1,022	1,192	25.23	30.64
Long-Term Leases	874.78	909.27	927.52	963.28	842.93	-
Long-Term Unearned Revenue	11.41	11.53	11.96	12.63	13.06	8.51
Long-Term Deferred Tax Liabilities	253.29	265.03	282.25	275.44	19.03	8.9
Other Long-Term Liabilities	-	-	-	407.82	-	-
Total Liabilities	7,392	7,843	7,104	7,076	3,321	1,767
Common Stock	156.66	156.66	128.85	99.16	69.53	53
Additional Paid-In Capital	1,397	1,397	1,361	1,391	1,009	985.9
Retained Earnings	1,375	1,341	1,379	1,109	856.89	678.26
Treasury Stock	-189.28	-97.81	-7.15	-14.78	-25.75	-
Comprehensive Income & Other	0.08	0.12	-	-	-	-
Total Common Equity	2,739	2,797	2,861	2,585	1,910	1,717
Minority Interest	-16.66	-16.68	-16.51	-16.59	-16.72	-15.45
Shareholders' Equity	2,723	2,781	2,845	2,568	1,893	1,702
Total Liabilities & Equity	10,115	10,623	9,949	9,644	5,214	3,469
Total Debt	4,524	4,342	3,696	2,935	1,282	104.72
Net Cash (Debt)	-3,783	-3,516	-2,788	-1,999	-298.88	1,517
Net Cash Growth	-	-	-	-	-	297.22%
Net Cash Per Share	-24.56	-22.78	-18.03	-13.17	-2.14	13.19
Filing Date Shares Outstanding	156.66	154.49	154.62	154.69	141	139.73
Total Common Shares Outstanding	156.66	154.49	154.62	154.69	141	139.73
Working Capital	-854.09	-784.78	-922.54	-285.78	76	1,075
Book Value Per Share	17.49	18.11	18.50	16.71	13.54	12.29
Tangible Book Value	200.78	255.83	365.8	251.51	1,450	1,626
Tangible Book Value Per Share	1.28	1.66	2.37	1.63	10.28	11.64
Buildings	-	906.25	902.64	891.8	369.39	358.62
Machinery	-	312.13	277.99	225.09	158.25	119.01
Construction In Progress	-	253.85	202.01	180.56	73.91	3.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.